Stay updated on Pembrolizumab in Hypermutation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Hypermutation Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, signaling a small metadata update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-07-03T23:17:01.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.6.2 was added, replacing Revision: v3.6.0. This signals a minor version update to the site with no changes to the study details or substantive content.
    Difference
    0.0%
    Check dated 2026-06-27T01:49:18.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Recruitment status now shows no longer looking for participants, indicating enrollment is closed. The page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header alongside the new revision tag v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:25:18.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page introduces a new revision label (v3.5.5), replacing the previous v3.5.4, indicating a minor update to the page's template or metadata.
    Difference
    0.0%
    Check dated 2026-06-05T12:11:18.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.3 to v3.5.4, signaling a new version of the page template or platform rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-05-15T05:10:52.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.5.2 to v3.5.3, signaling a newer version of the page content. This change reflects a minor metadata update rather than alterations to study details.
    Difference
    0.0%
    Check dated 2026-04-30T18:53:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Hypermutation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.